Ad
Thursday, 21 December 2017
North Carolina accuses drugmaker Insys of scheme to push opioid
BOSTON (Reuters) - North Carolina sued Insys Therapeutics Inc on Thursday, accusing the pharmaceutical company of illegally pushing a powerful fentanyl-based cancer pain medicine called Subsys to boost profits amid the U.S. opioid epidemic.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment